Supplementary Dataset 3 from Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma

MLA

Craig J. Thomas, et al. Supplementary Dataset 3 from Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22469144.

APA

Craig J. Thomas, Lee J. Helman, Arnulfo Mendoza, Yiping Zhang, Huong-Lan Tran, Jiuping Ji, Fernanda I. Arnaldez, Marc Ferrer, Rajarshi Guha, Damien Y. Duveau, Michele Ceribelli, Xiaohu Zhang, Lu Chen, Michael V. Gormally, Kelli Wilson, Joshua T. Baumgart, Mindy I. Davis, & Christine M. Heske. (2023). Supplementary Dataset 3 from Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma. https://doi.org/10.1158/1078-0432.22469144

Chicago

Craig J. Thomas, Lee J. Helman, Arnulfo Mendoza, Yiping Zhang, Huong-Lan Tran, Jiuping Ji, Fernanda I. Arnaldez, et al. 2023. “Supplementary Dataset 3 from Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma,” March. doi:10.1158/1078-0432.22469144.